ConstructiveBio

@ELRIG_SCIENCE Drug Discovery turns 20 this week! We will be there!

Find out more:

RT @GENbio: Recoded E. coli Promises More Scalable Weight Loss Drug Production Synthetic bacteria can produce peptide chains containing non-canonical amino acids like weight loss drugs @BioConstructiv #NextGEN #GENbioprocessing #biopharmaceuticals

Our CSO and founder has been selected to receive the Heinrich Wieland Prize from the Boehringer Ingelheim Stiftung for the groundbreaking research that underpins our company.

Jim Weissman joined @BioConstructiv board of directors!

ML engineer: write synthetic genomes

As the market for GLP-1 agonists booms, The Observer UK explains how Constructive Bio has created a cleaner, more sustainable and efficient route to manufacturing the peptides.

Ready to explore non-canonical building blocks in proteins and peptides for cutting-edge results? Our new explainer breaks it down in 90 seconds: from chaos to clarity 🚀

Boston-based serial entrepreneur & synthetic biology pioneer Rahul K Dhanda joins our BoD as NED. Rahul will deliver diverse expertise in platform development, strategic partnering, commercialisation & company-building, complementing the current team.

Paul Wallace joins Constructive with 25+ years of international Business Development experience, commercialising innovative platforms and therapeutics. Together we will accelerate commercialisation of our ground-breaking genome reprogramming technology

We're excited to welcome Dr Paul Wallace as our new Chief Business Officer and Rahul Dhanda as Non-Executive Director to our Board of Directors. Link to full PR here: #Appointments #CBO #NED #GenomeSynthesis

Welcome to the team @rahulkdhanda!

RT @AmadeusCapital: In a @TEDTalks Prof Jason Chin, the scientific brain behind @BioConstructiv, describes the rewriting of the genetic blueprint of cells to create a virus-resistant organism - the largest synthetic genome ever made! Click here to listen:

RT @SynBioBeta: Constructive bio launches with $15m seed investment to re-engineer biology, creating new classes of enzymes, pharmaceuticals and biomaterials

RT @1nterestingTech: "Re-engineering biology, Constructive Bio scores $15 million to make new class of enzymes" Read more #GlobalGoals #Sustainability #UNSDGs

RT @UKTNofficial: Cambridge’s Constructive Bio launches with £12.5m to rewrite DNA. 💡 ➡️ #deeptech #dna #biotech #biology #investment #UKtech